checkAd

    DGAP-News  661  0 Kommentare HAEMATO AG - H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR 5.93 million, compared to prior year period

    DGAP-News: HAEMATO AG / Key word(s): Half Year Results/Dividend
    HAEMATO AG - H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth
    40% to EUR 5.93 million, compared to prior year period

    29.08.2016 / 09:52
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------------

    Corporate News der HAEMATO AG:

    H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR
    5.93 million, compared to prior year period

    In the second quarter 2016 HAEMATO AG, Berlin (ISIN: DE0006190705),
    achieved IFRS Group sales of EUR 74.33 million (prior year period: EUR
    56.16 million), a growth of 31.9% was achieved. The pleasant sales
    achievement in the first quarter of EUR 67.94 million was run up by 9.4%.

    In the first half-year HAEMATO achieved IFRS Group sales of EUR 142.27
    million (prior year period: EUR 101.48 million), a growth of 40% was
    produced.
    The operating result (EBIT) increased as well by 40% to EUR 5.93 million
    (prior year period: EUR 4.21 million). The annual general meeting was held
    in June 2016. The shareholders decided again on a dividend pay of 30 Cent
    per share.

    "HAEMATO expanded sales from first quarter to second quarter. For the
    following quarters we expect as well a good business development", says Dr.
    Christian Pahl, Member of the Management Board of HAEMATO AG.

    About HAEMATO:

    HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of the
    business activities lies on the growth markets of patent free and patent
    protected medicinal products. Focal points are therapies with cancer, HIV
    and other chronic diseases.

    HAEMATO AG is listed in the Entry Standard (Open Market) on the
    Frankfurt Stock Exchange. Key figures for the share of HAEMATO AG:
    Subscribed capital: EUR 20,778,898
    Listed shares: ordinary shares
    ISIN: DE000619070
    WKN: 619070
    Stock symbol: HAE




    Contact:
    HAEMATO AG, Investor Relations
    Telefon: +49 (0)30 897 30 86 70
    ir@haemato.de


    ---------------------------------------------------------------------------

    29.08.2016 Dissemination of a Corporate News, transmitted by DGAP - a
    service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Archive at www.dgap.de

    ---------------------------------------------------------------------------

    496481 29.08.2016


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News HAEMATO AG - H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR 5.93 million, compared to prior year period DGAP-News: HAEMATO AG / Key word(s): Half Year Results/Dividend HAEMATO AG - H1 2016: Sales growth 40% to EUR 142.27 million, EBIT-growth 40% to EUR 5.93 million, compared to prior year period 29.08.2016 / 09:52 The issuer is solely responsible for …